HRSA-26-052 TA Call Presentation.pdf

PDF 718 KB Posted

Attached to
​Sickle Cell Disease Regional Care Excellence (SoRCE) Program
Opportunity number
HRSA-26-052
Issued by

About this file

HRSA-26-052 TA Call Presentation.pdf

View the file

Other files

File Type Posted
FAQs HRSA-26-052.pdf PDF
FAQs -HRSA-26-052.pdf PDF
FAQs - SoRCE Questions_6.11.26.pdf PDF
HRSA-26-052 Final.pdf PDF
HRSA-26-052 Final.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Sickle Cell Disease Regional Care Excellence (SoRCE) Program

Notice of Funding Opportunity

HRSA-26-052

Technical Assistance Webinar

Division of Services for Children with Special Health Needs (DSCSHN) Genetic Services Branch (GSB) Maternal and Child Health Bureau (MCHB)

Agenda

•Brief overview of HRSA-26-052 SoRCE NOFO

• Program Overview

• Eligibility

• Funding

• Application Contents

• Supplements

Agenda

The SoRCE Program

• Funded through the Sickle Cell Treatment Act, which was most recently reauthorized in 2024.

• The Sickle Cell Disease Regional Care Excellence (SoRCE) Program aims to improve the health of people with sickle cell disease (SCD). It does this by:

• Expanding access to care.

• Improving the quality of care.

• Tracking quality of life indicators.

• The program will:

• Work with clinicians to improve SCD care.

• Connect people and families to high-quality clinical care and community services.

The SoRCE Program Structure

• Regional Coordinating Hubs (RCHs): The award recipient will be the RCH, which may be a federally qualified health center, nonprofit hospital, clinic, or a university health center with SCD experience.

Each RCH is required to partner with at least three Clinical- Community Spokes (CCSs).

• Clinical-Community Spokes (CCSs): Each CCS includes one clinical center partnered with at least one community-based organization

(CBO).

• This structure increases the number of regional hubs and connects the specialized care of RCHs and the local services of CCSs, reaching people with SCD where they live.

The SoRCE Program Structure

•What is a Clinical-Community Spoke?

•A CCS is a team made up of a clinical center working closely with one or more community-based organizations (CBOs).

Together, they help connect people with SCD and their families to:

oHigh quality clinical care.

oCommunity-based services.

•Each RCH and its CCS partners will form a regional network. These networks improve the health and well-being of people with SCD and their families.

HRSA will fund up to one award recipient in each region below, and recipients will undertake activities to support all states within the region. Seven regions have been programmatically designated as HRSA SoRCE Regions:

7 Regions States

Northeast Connecticut, Maine, Massachusetts, New Hampshire, New York, Rhode Island, Vermont

Mid-Atlantic Delaware, District of Columbia, Maryland, New Jersey, Pennsylvania, Puerto Rico, Virginia, Virgin Islands, West Virginia

Southeast Georgia, North Carolina, South Carolina South Alabama, Florida, Mississippi, Tennessee

Midwest Kentucky, Illinois, Indiana, Michigan, Minnesota, North Dakota, South Dakota, Ohio, Wisconsin Heartland Arkansas, Iowa, Kansas, Louisiana, Missouri, Nebraska, Oklahoma, Texas

West Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, Wyoming, the Trust Territory of the Pacific Islands, American Samoa

Sickle Cell Regional Care Excellence (SoRCE) Regional Structure

Learn more at https://mchb.hrsa.gov

Sickle Cell Regional Care Excellence (SoRCE) Regional Structure

Eligible Applicants

• You can apply if your organization is a Federally-qualified health center, a nonprofit hospital or clinic, or a university health center that provides primary health care, that:

1. Has a collaborative agreement with a community-based sickle cell disease organization or a nonprofit entity with experience in working with individuals who have sickle cell disease; and

2. You as a Federally-qualified health center, the nonprofit hospital or clinic, the university health center, the organization or entity described in clause 1, can demonstrate at least 5 years of experience in working with individuals who have sickle cell disease.

• See NOFO for full list of types of organizations.

• Individuals are not eligible to apply.

Funding

• 7 awardees expected

• Up to $950,000 per year

• Type of award: Cooperative Agreements

• Type of applications: New

• Period of Performance: September 1, 2026 - August

31, 2030 (4 years)

Funding Opportunity Goals

• By August 31, 2030, award recipients and their partners will:

• Serve at least 30% of people with SCD in their region.

• Increase the percent of eligible people receiving disease-modifying therapies (DMTs) by 5%, compared to baseline established at the end of year 1.

• Collect and report annual data in two areas:

• Quality of care: Emergency department use among people served.

• Quality of life: High school graduation (or equivalent) rate among people served.

• Note: Award recipients are required to report data each year.

Application Contents

Project narrative

• Introduction

• Need

• Approach

• Work plan

• Resolving challenges

• Performance reporting and evaluation

• Sustainability

• Organizational information

• Budget and budget narrative

Application Contents

SoRCE Program-Specific Instructions In your application ensure that details related to the following activities are included:

• As the Regional Coordinating Hub, you must:

o Create a network of at least three CCSs across your region.

Each CCS must have one clinical center partnered with at least one community-based organization (CBO). Clinical centers and CBOs must work as a unit to connect people and families with services necessary to access health care.

o Choose CCSs to serve the entire region and who have clinicians experienced in caring for individuals living with SCD.

oSpend at least 40% of your budget on CCSs to ensure that all clinical centers and community-based organizations have sufficient resources for planned activities.

SoRCE Program-Specific Instructions (cont’d)

• Partner with the HRSA-funded Sickle Cell Disease National Coordinating Center (SCDNCC)

• Share provider training and educational resources with the SCDNCC.

• Receive technical assistance from SCDNCC to build local services and to respond to emerging needs or issues in the SCD community.

• Participate in SCDNCC workgroups and attend the SCDNCC annual meeting.

• Work with the SCDNCC on CQI projects.

• Report data regularly to HRSA or third parties.

• Follow the guidance in the Performance measurement, evaluation, and continuous quality improvement (CQI) section within the

NOFO.

Performance measurement, evaluation, and continuous quality improvement (CQI)

We expect you to measure your performance, evaluate your program, and conduct CQI activities. Actions include:

• Measuring performance on key activities and program objectives.

oThis includes Discretionary Grants Information System (DGIS) measures noted in the Reporting section.

oIf using proxy data, you must discuss this approach with HRSA after awarded.

Performance measurement, evaluation, and CQI (cont’d)

You must collect and report annually on added measures that align with program goals and objectives including:

• Percent of individuals with SCD living in the region that you and your CCS partners served.

oThis includes a numerator (the number of individuals you and your clinical center partners served) as well as a denominator (your estimate of the number of individuals with SCD living in your region).

• Percent of individuals served who are on disease modifying therapy

(DMT).

oThis includes a numerator (the number of individuals you serve on

DMT) as well as a denominator (the number of individuals you serve who are eligible for DMT).

During the project period, you must also develop a plan to collect data on two additional measures.

Baseline data must be reported by August 31, 2027.

• The specific measures are:

oThe rate of emergency department use among people served.

Award recipients are expected to finalize this measure in collaboration with HRSA and the SCDNCC.

oThe high school graduation rate or equivalent among youth served.

Award recipients are expected to finalize this measure in collaboration with HRSA and the SCDNCC.

Performance measurement, evaluation, and CQI (cont’d)

Attachments

• Attachment 1: Work plan

• Attachment 2: Staffing plan and job descriptions

• Attachment 3: Biographical Sketches

• Attachment 4: Project organizational chart

• Attachment 5: Agreements with other entities

• Attachment 6: Tables and Charts

• Attachment 7: SoRCE Emerging Issues Supplement (optional)

• Attachment 8: Key Contacts

• Attachment 9: Project Performance Site Locations

• Attachment 10-15: Other relevant documents

Optional Supplement

• Funding selection for the SoRCE Emerging Issues Supplemental award

• Up to $250,000 for one-year can be used to support emerging issues in SCD care. See

Attachment 7 for application requirements.

• We plan to fund awards in 4 12-month budget periods for a total 4 year period of performance from 09/01/2026 to 08/31/2030.

• Each year, the SoRCE Emerging Issues Supplement funding may be awarded to recipients selected for the SoRCE program.

• Supplemental funding may be awarded in any of the four project years. Supplements will be funded in the order of the objective review score earned by the applicant in the base competition.

• These are one time, one-year supplements.

• This funding selection method only applies to applicants requesting additional funding under the supplement. Applying for this supplement does not impact the base application score.

Required Forms

• SF-424 (Application for Federal Assistance)

• Project Abstract Summary Form

• Grants.gov Lobbying Form

Reporting

• Annual Progress Reports

• Annual Performance Reports – submit through the Discretionary Grants Information

System (DGIS).* See NOFO for DGIS form assignments.

Type of Report Reporting Period Available Date Report Due Date

a) New Competing Performance Report September 1, 2026- August

31, 2027 (administrative data and performance measure projections, as applicable)

Period of performance start date

90 days from the available date

b) Non-Competing Performance Report

September 1, 2026- August 31, 2027 September 1, 2027- August 31, 2028 September 1, 2028- August 31, 2029

Beginning of each budget period (Years 2–4, as applicable)

90 days from the available date

c) Project Period End Performance Report

September 1, 2029- August 31, 2030

Period of performance end date

120 days from the available date

* DGIS Website, DGIS Wiki https://mchb.hrsa.gov/data-research/discretionary-grants-information-system-dgis https://help.hrsa.gov/display/public/EHBSKBFG/DGIS+User+Guide?preview=/141001396/143819486/DGIS%20User%20Guide_part%202.pdf

Budget and Budget Narrative

Budget Tips and Reminders

• Total Award Amount – $950,000 annually

• Five Year Project Period – You must provide the SF-424A Budget form and a Budget

Narrative for all five budget periods. The SF-424A for Year 5 can be submitted as a separate attachment

• The Indirect Cost Agreement should be included with your application, if applicable.

If you do not have an IDC Agreement you can use the De Minimis Rate of 15% if claiming indirect costs (please indicate, you are using the De Minimis Rate in your budget narrative).

• Applicants must completely breakdown all costs in the Budget Narrative and costs must correspond with the SF-424A.

Budget Requirements

Personnel & Fringe - Cost Category Personnel: Are all positions described in the narrative also included in the budget?

Example:

• full name (or indicate if the position is vacant)

• position title

• annual/base salary

• Federal amount requested

• percent of effort/FTE funded under HRSA grant (or if in-kind, include the source)

• description of role/responsibilities on project

**Note Salary Cap is $228,000**

Fringe Benefits: You must include the means by which these fringe benefits were calculated and what is included in the fringe benefits.

Travel - Cost Category

Travel: Itemize and justify costs requested

Example:

X Conference, June 25-27, 2027, Los Angeles, CA. Jane Doe, RN and Jim Rogers, MSW will attend. Each attendee will have the following costs:

Airfare, $300 Hotel, $450 Per diem, $150 Registration, $350 Total cost = $1250/attendee x 2 attendees = $2,500

Supplies & Equipment - Cost Category

Supplies: Provide clear justification for all supplies requested.

Example:

General office supplies, $500 based on 5 staff and $100 per staff person. Our department provides basic office supplies (printer paper, pens, paper clips, binder clips, staplers) to each employee at a cost of $100/employee.

Equipment: Is tangible, non-expendable property charged directly to an award having a useful life of more than one year and an acquisition value of $10,000 or more per unit or whatever value your organizations capitalizes equipment.

Each item of equipment requested must have its specific cost per unit listed and its need explained/justified.

Contractual & Other - Cost Category Contracts: Provide a clear explanation as to the purpose of each contract/subaward, how the costs were estimated, and the specific contract/subaward deliverables.

Other: Each item or service being requested in the Other budget category must have its specific cost listed and the need explained/justified.

Example:

• printing costs

• telephone fees

• training activities

• office space rent (if not already included in IDC)

Key Information

System for Awards Management (SAM) and Grants.gov registrations

Ceiling amount per year is $950,000.00 (inclusive of direct & indirect costs)

All HRSA awards are subject to the regulations at 2 CFR Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards, modifications at 2 CFR Part 300, and any superseding regulations https://www.ecfr.gov/current/title-2/part-200 https://www.ecfr.gov/current/title-2/part-200 https://www.ecfr.gov/current/title-2/subtitle-B/chapter-III/part-300

Contact information scdprograms@hrsa.gov

����Sickle Cell Disease Regional Care Excellence (SoRCE) Program�Notice of Funding Opportunity �HRSA-26-052�Technical Assistance Webinar�
Agenda
The SoRCE Program
The SoRCE Program Structure
The SoRCE Program Structure
Slide Number 6
����
Eligible Applicants
Funding
Funding Opportunity Goals
Application Contents
SoRCE Program-Specific Instructions
SoRCE Program-Specific Instructions (cont’d)
Performance measurement, evaluation, and continuous quality improvement (CQI)
Performance measurement, evaluation, and CQI (cont’d)
Performance measurement, evaluation, and CQI (cont’d)
Attachments
Optional Supplement
Required Forms
Reporting
Budget and Budget Narrative�
Budget Tips and Reminders
Budget Requirements
Personnel & Fringe - Cost Category�
Travel - Cost Category
Supplies & Equipment - Cost Category
Contractual & Other - Cost Category�
Key�Information
Contact information

File details come from the government source that posted it. Updated .